Samsung Bio Nabs $1B Manufacturing Contract With Undisclosed US Pharma

Samsung Biologics has entered into a $1.06 billion agreement with an unnamed U.S. pharmaceutical company, according to a public disclosure the Korean manufacturer made on Tuesday.